SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Bal Pharma informs about trading window closure

20 Jun 2025 Evaluate
Bal Pharma has informed that the trading window for dealing with the securities of the Company on the designated persons and their immediate relatives will be closed from 18 July 2025 and up to 48 hours of the declaration of the unaudited financial results of the Company for the quarter ended 30/06/2025. The date of the Board meeting for declaration of the unaudited financial results will be intimated to the exchange in due course.

The above information is a part of company’s filings submitted to BSE.

Bal Pharma Share Price

78.47 0.37 (0.47%)
20-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1668.00
Dr. Reddys Lab 1232.25
Cipla 1228.90
Zydus Lifesciences 936.35
Lupin 2328.60
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×